Opioids Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Japan, China, India, Australia, Argentina, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Report ID: GMI4432

Summary Methodology

Opioids Market size is projected to experience substantial progress from 2019 to 2025.

Opioids are class of drugs that are derived from opium poppy plant and are used for several medical purposes, especially for pain management and are most commonly prescribed as painkillers. The prescription opioids help in blocking pain signals between the brain and other body parts. Additionally, opioids can also be prescribed for constipation, nausea, drowsiness, confusion and slowed breathing.

Global Opioids Market Growth, By Region, 2018 and 2025 (USD Million)
Global Opioids Market Growth, By Region, 2018 and 2025 (USD Million)

Get more details on this report - Request Free Sample PDF

Chronic pain management has been a very critical public healthcare concern across the globe and has resulted in rising demand for opioid drugs. As per the American Academy of Family Physicians, the number of opioids prescription in the U.S. has been on constant rise in the last few years. Increase in number of people preferring opioid drugs for chronic pain management and will enhance the market growth in the forthcoming years.

Increase in prevalence of orthopedic disorders, such as arthritis, fibromyalgia, joint pain and osteoporosis is one of the major primary factor responsible for boosting the opioids market. Opioids play a significant role in several acute post-operative procedures in order to provide adequate analgesia. As per the statistics published by the Center for Disease Control and Prevention (CDC), in U.S., more than 30 million people suffer from osteoarthritis every year. Also, as per the Arthritis UK, around 1 to 5 adults over 45 years of age had osteoarthritis in knee and 1 to 9 adults had osteoarthritis in hip. Hence, increase in number of orthopedic disorders will ultimately augment the opioids market. However, use of opioids is considered to pose several disadvantages such as addiction, drug abuse, drug overdose etc.

On the basis of drug class, the opioids are bifurcated as natural, semi-synthetic and fully synthetic. Synthetic opioids market is estimated to hold significant market share in the year 2018 and follow similar trends over the estimation period. As per the recent research article, fentanyl is one of the most common synthetic opioid in the U.S. and is around 50-100 times more effective than morphine. Hence, the above mentioned factors will have significant impact on the market growth in the near future.

Based on the release type, the market is segmented as immediate-release/short-acting opioid and extended-release/long-acting opioid. The immediate release opioid market is expected to hold significant share in 2018 and forecasted to grow at a substantial rate over the forthcoming years. As per the National Academics of Sciences Engineering Medicine, in the U.S., annually over 150 million opioid prescriptions are dispensed. Increase in preference of physicians in prescribing immediate-release opioids for treating chronic and acute pain will enhance the market growth in the future.

The product segment is bifurcated as codeine, fentanyl, oxycodone, methadone, morphine, hydrocodone, tramadol, propoxyphene and others. Oxycodone is projected to hold major market share in 2018 and witness significant growth over the forecast timeframe. The rapid growth of oxycodone is owing to advantages such as good efficacy and tolerability profile. Oxycodone is the most commonly prescribed opioid by the doctors in order to relive severe to moderate type of pain. Hence, the above mentioned factors will have significant impact on the market growth.

Application of opioids is segmented as pain management, cough treatment, diarrhea treatment, de-addiction and others. Pain management segment is further bifurcated as neuropathic, migraine, orthopedic and musculoskeletal, cancer pain and others. The application of opioids in pain management is projected to hold majority market share over the estimation period. As per the American Society of Clinical Oncology, more than half of the cancer patients experience moderate to severe pain during the treatment. Hence, increase in need of opioids to treat and manage the chronic pain among the patients will boost the business growth in the near future.

On the basis of brand, the market is segmented into branded and generic. The generic opioids market is estimated to hold substantial amount of market share in 2018 and follow the similar trend over the forthcoming years. Presence of generic versions of the drug in the market over the last few years and growing prescribing trends has resulted in augmenting the market growth. Hence, increase in number of physician prescriptions of generic drugs will resulting in enhancing the opioids market growth in the future.

Based on route of administration, the market is segmented as oral, injectable, transdermal and others. Oral is further segmented as buccal and sublingual, whereas injectable is segmented as intramuscular, intravenous, subcutaneous, intrathecal and others. The oral route of administration of opioids is projected to hold significant market share in 2018. In general, the oral route is considered to be the preferred route of administration owing to ease of drug administration and proper bioavailability of opioids. Therefore, the above factors will impact the opioids market growth positively in the future.

On the basis of receptor binding, the market is bifurcated as full agonist, partial/mixed agonist and antagonist. Full agonist opioids market is forecasted to witness rapid growth over the upcoming years. Majority of the opioid products fall under full agonist type of receptor binding. Also, advantages offered such as selective binding to the opioids receptors and limited side effects will lead to augmenting the business growth.

U.S. opioids market is projected to hold majority market share and maintain similar trend over the forthcoming years. Growing consumption of opioids for treating chronic pain and rise in awareness among the people regarding pain management will result in enhancing the opioid market growth in the neat future.

Some of the major market players involved in the global opioids market are Mallinckrodt Pharmaceuticals, Teva Pharmaceutical, Endo International, Purdue Pharma, Amneal Pharmaceuticals among others. These players are focusing on major market strategies such as mergers, acquisitions and geographic expansion in order to strengthen their market position. For instance, Purdue Pharma is rapidly planning to enter in the developing regions of Asia Pacific, Latin America, and Middle East &  Africa.

Opioids Market, By Class, 2014-2025 (USD Million)

  • Natural
  • Semi-synthetic
  • Fully synthetic

Opioids Market, By Release Type, 2014-2025 (USD Million)

  • Immediate-release/Short-acting opioid
  • Extended-release/Long-acting opioid

Opioids Market, By Product, 2014-2025 (USD Million)

  • Codeine
  • Fentanyl
  • Oxycodone
  • Methadone
  • Morphine
  • Hydrocodone
  • Tramadol
  • Propoxyphene
  • Others

Opioids Market, By Application, 2014-2025 (USD Million)

  • Pain management
    • Neuropathic 
    • Migraine
    • Orthopedic and Musculoskeletal
      • Arthritis
      • Fibromyalgia
      • Others
    • Cancer Pain
      • Brain
      • Breast
      • Colorectal
      • Blood
      • Skin
      • Prostate
      • Others
    • Others
  • Cough treatment
  • Diarrhea treatment
  • De-addiction
  • Others

Opioids Market, By Brand, 2014-2025 (USD Million)

  • Branded
  • Generic

Opioids Market, By Route of Administration, 2014-2025 (USD Million)

  • Oral
    • Buccal
    • Sublingual
  • Injectable
    • Intramuscular
    • Intravenous 
    • Subcutaneous
    • Intrathecal
  • Transdermal
  • Others

Opioids Market, By Mechanism of Action, 2014-2025 (USD Million)

  • Full Agonist
  • Partial/Mixed Agonist
  • Antagonist

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • Latin America
    • Argentina
    • Mexico
    • Brazil
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Company Profiles:

  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceutical
  • Endo International
  • Purdue Pharma
  • Amneal Pharmaceuticals
  • KVK Tech
  • West-Ward Pharmaceuticals
  • Lupin
  • Pfizer
  • Acura Pharmaceuticals
  • Cipher Pharmaceutical
  • Johnson & Johnson
  • Janssen Pharmaceuticals
  • Sun Pharmaceutical
  • Grunenthal

What Information does this report contain?

Historical data coverage: 2016 to 2020; Growth Projections: 2021 to 2027.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Customize this Report

Pre Book Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X